Length of stay and inpatient charges of total knee arthroplasty in China: analysis of a national database.


Journal

Chinese medical journal
ISSN: 2542-5641
Titre abrégé: Chin Med J (Engl)
Pays: China
ID NLM: 7513795

Informations de publication

Date de publication:
05 Sep 2023
Historique:
medline: 6 9 2023
pubmed: 23 5 2023
entrez: 23 5 2023
Statut: epublish

Résumé

There are limited data on the resource utilization of total knee arthroplasty (TKA) in China. This study aimed to examine the length of stay (LOS) and inpatient charges of TKA in China, and to investigate their determinants. We included patients undergoing primary TKA in the Hospital Quality Monitoring System in China between 2013 and 2019. LOS and inpatient charges were obtained, and their associated factors were further assessed using multivariable linear regression. A total of 184,363 TKAs were included. The LOS decreased from 10.8 days in 2013 to 9.3 days in 2019. The admission-to-surgery interval decreased from 4.6 to 4.2 days. The mean inpatient charges were 61,208.3 Chinese Yuan. Inpatient charges reached a peak in 2016, after which a gradual decrease was observed. Implant and material charges accounted for a dominating percentage, but they exhibited a downward trend, whereas labor-related charges gradually increased. Single marital status, non-osteoarthritis indication, and comorbidity were associated with longer LOS and higher inpatient charges. Female sex and younger age were associated with higher inpatient charges. There were apparent varieties of LOS and inpatient charges among provincial or non-provincial hospitals, hospitals with various TKA volume, or in different geographic regions. The LOS following TKA in China appeared to be long, but it was shortened during the time period of 2013 to 2019. The inpatient charges dominated by implant and material charges exhibited a downward trend. However, there were apparent sociodemographic and hospital-related discrepancies of resource utilization. The observed statistics can lead to more efficient resource utilization of TKA in China.

Sections du résumé

BACKGROUND BACKGROUND
There are limited data on the resource utilization of total knee arthroplasty (TKA) in China. This study aimed to examine the length of stay (LOS) and inpatient charges of TKA in China, and to investigate their determinants.
METHODS METHODS
We included patients undergoing primary TKA in the Hospital Quality Monitoring System in China between 2013 and 2019. LOS and inpatient charges were obtained, and their associated factors were further assessed using multivariable linear regression.
RESULTS RESULTS
A total of 184,363 TKAs were included. The LOS decreased from 10.8 days in 2013 to 9.3 days in 2019. The admission-to-surgery interval decreased from 4.6 to 4.2 days. The mean inpatient charges were 61,208.3 Chinese Yuan. Inpatient charges reached a peak in 2016, after which a gradual decrease was observed. Implant and material charges accounted for a dominating percentage, but they exhibited a downward trend, whereas labor-related charges gradually increased. Single marital status, non-osteoarthritis indication, and comorbidity were associated with longer LOS and higher inpatient charges. Female sex and younger age were associated with higher inpatient charges. There were apparent varieties of LOS and inpatient charges among provincial or non-provincial hospitals, hospitals with various TKA volume, or in different geographic regions.
CONCLUSIONS CONCLUSIONS
The LOS following TKA in China appeared to be long, but it was shortened during the time period of 2013 to 2019. The inpatient charges dominated by implant and material charges exhibited a downward trend. However, there were apparent sociodemographic and hospital-related discrepancies of resource utilization. The observed statistics can lead to more efficient resource utilization of TKA in China.

Identifiants

pubmed: 37218077
doi: 10.1097/CM9.0000000000002220
pii: 00029330-990000000-00623
pmc: PMC10476770
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2050-2057

Informations de copyright

Copyright © 2023 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license.

Références

BMJ Qual Saf. 2011 Dec;20(12):1069-74
pubmed: 21768211
Clin Orthop Relat Res. 2006 Nov;452:44-8
pubmed: 16906110
Acta Orthop. 2018 Apr;89(2):184-189
pubmed: 29160123
Acta Orthop. 2015 Feb;86(1):41-7
pubmed: 25323798
Bone Joint J. 2019 Oct;101-B(10):1209-1217
pubmed: 31564156
J Arthroplasty. 2010 Sep;25(6 Suppl):58-61
pubmed: 20570479
Lancet. 2008 Oct 25;372(9648):1493-501
pubmed: 18930531
Lancet. 2018 Nov 3;392(10158):1672-1682
pubmed: 30496082
J Arthroplasty. 2017 Jun;32(6):1769-1772
pubmed: 28274618
BMJ. 2010 Feb 11;340:c165
pubmed: 20150193
J Arthroplasty. 2012 Sep;27(8):1423-1428.e1
pubmed: 22425299
Clin Orthop Relat Res. 2011 Jan;469(1):87-94
pubmed: 20694537
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
JAMA Surg. 2015 Oct;150(10):990-8
pubmed: 26288005
Orthop Clin North Am. 2020 Apr;51(2):169-176
pubmed: 32138855
J Arthroplasty. 2019 Aug;34(8):1575-1580
pubmed: 31064724
J Bone Joint Surg Am. 2009 Jul;91(7):1621-9
pubmed: 19571084
Chronic Dis Transl Med. 2017 Apr 29;3(2):75-81
pubmed: 29063059
J Bone Joint Surg Am. 2017 Mar 1;99(5):402-407
pubmed: 28244911
J Arthroplasty. 2020 Mar;35(3):633-637
pubmed: 31757697
J Arthroplasty. 2015 Oct;30(10):1710-5
pubmed: 26009468
J Arthroplasty. 2019 Sep;34(9):2124-2165.e1
pubmed: 31182407
Lancet. 2017 Dec 9;390(10112):2584-2594
pubmed: 29231837
Arthritis Rheumatol. 2016 Mar;68(3):648-53
pubmed: 26474054
N Engl J Med. 2016 Sep 1;375(9):905-6
pubmed: 27579659
JAMA. 2012 Sep 26;308(12):1227-36
pubmed: 23011713
Int J Environ Res Public Health. 2020 Dec 15;17(24):
pubmed: 33334027
J Bone Joint Surg Am. 2020 Mar 4;102(5):404-409
pubmed: 31714468
J Arthroplasty. 2020 Apr;35(4):1079-1083
pubmed: 31759799
Can J Surg. 2010 Jun;53(3):175-83
pubmed: 20507790
J Arthroplasty. 2011 Dec;26(8):1418-26.e1-2
pubmed: 21277159
Arch Intern Med. 2002 Jan 28;162(2):185-90
pubmed: 11802752

Auteurs

Huizhong Long (H)

Department of Orthopedics, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China.

Chao Zeng (C)

Department of Orthopedics, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China.
Hunan Key Laboratory of Joint Degeneration and Injury, Changsha, Hunan 410008, China.
Hunan Engineering Research Center for Osteoarthritis, Changsha, Hunan 410008, China.
National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China.

Ying Shi (Y)

China Standard Medical Information Research Center, Shenzhen, Guangdong 518054, China.

Haibo Wang (H)

China Standard Medical Information Research Center, Shenzhen, Guangdong 518054, China.
Clinical Trial Unit, First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong 510080, China.

Dongxing Xie (D)

Department of Orthopedics, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China.

Guanghua Lei (G)

Department of Orthopedics, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China.
Hunan Key Laboratory of Joint Degeneration and Injury, Changsha, Hunan 410008, China.
Hunan Engineering Research Center for Osteoarthritis, Changsha, Hunan 410008, China.
National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH